Showing results (431-440 of 655) with videos related to
Sort By:
Pageof 66
Communications Biology|November 1, 2022
Rewiring glucose metabolism improves 5-FU efficacy in p53-deficient/KRASG12D glycolytic colorectal tumorsMarlies C Ludikhuize, Sira Gevers, Nguyen T B Nguyen, et al.The Journal of Biological Chemistry|April 17, 2004
Aberrant polycystin-1 expression results in modification of activator protein-1 activity, whereas Wnt signaling remains unaffectedNgoc Hang Le, Paola van der Bent, Gerwin Huls, et al.Plos Biology|November 28, 2012
The nuclear effector of Wnt-signaling, Tcf1, functions as a T-cell-specific tumor suppressor for development of lymphomasMachteld M Tiemessen, Miranda R M Baert, Tom Schonewille, et al.Proceedings of the National Academy of Sciences of the United States of America|January 10, 2018
Troy+ brain stem cells cycle through quiescence and regulate their number by sensing niche occupancyOnur Basak, Teresa G Krieger, Mauro J Muraro, et al.Proceedings of the National Academy of Sciences of the United States of America|December 29, 2016
Aberrantly expressed LGR4 empowers Wnt signaling in multiple myeloma by hijacking osteoblast-derived R-spondinsHarmen van Andel, Zemin Ren, Iris Koopmans, et al.Journal of Virology|August 9, 2023
SARS-CoV-2 Omicron entry is type II transmembrane serine protease-mediated in human airway and intestinal organoid modelsAnna Z Mykytyn, Tim I Breugem, Maarten H Geurts, et al.EMBO Reports|October 25, 2021
Modelling of primary ciliary dyskinesia using patient-derived airway organoidsJelte van der Vaart, Lena Böttinger, Maarten H Geurts, et al.Science (New York, N.Y.)|March 13, 2010
Lgr6 marks stem cells in the hair follicle that generate all cell lineages of the skinHugo J Snippert, Andrea Haegebarth, Maria Kasper, et al.Cell Reports|September 25, 2012
Lgr5(+ve) stem/progenitor cells contribute to nephron formation during kidney developmentNick Barker, Maarten B Rookmaaker, Pekka Kujala, et al.Proceedings of the National Academy of Sciences of the United States of America|March 14, 2024
Epidermal growth factor receptor (EGFR) is a target of the tumor-suppressor E3 ligase FBXW7Matteo Boretto, Maarten H Geurts, Shashank Gandhi, et al.Pageof 66